| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 5e-08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 1e-05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |